Six Months of Breastfeeding Tied to Lower Odds of Developmental Delays
By Lori Solomon HealthDay Reporter
TUESDAY, March 25, 2025 -- Exclusive or longer duration of breastfeeding (at least six months) is associated with reduced odds of developmental delays, according to a study published online March 24 in JAMA Network Open.
Inbal Goldshtein, Ph.D., from the KI Research Institute in Kfar Malal, Israel, and colleagues estimated the independent association between breastfeeding and attainment of developmental milestones or neurodevelopmental conditions. The analysis included data from 570,532 children identified through a national network for routine child development surveillance.
The researchers found that 52.1 percent of children were breastfed for at least six months. Breastfeeding for at least six months was associated with fewer delays in attaining language and social or motor developmental milestones versus less than six months of breastfeeding (adjusted odds ratios, 0.73 for exclusive breastfeeding and 0.86 for nonexclusive breastfeeding). Similar findings were seen among 37,704 sibling pairs, with children who were breastfed for at least six months showing lower likelihood of milestone attainment delays (odds ratio, 0.91) or being diagnosed with neurodevelopmental conditions (odds ratio, 0.73) versus their sibling with less than six months of breastfeeding or no breastfeeding.
"In this cohort study, breastfeeding persistence was associated with lower incidence of developmental delays," the authors write. "These findings may guide parents, caregivers, and public health initiatives in promoting optimal child development."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-26 06:00
Read more

- IBD Activity May Increase Risk for Clostridioides Difficile Infection
- Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis
- Steep Decline In Fertility Among U.S. Women Younger Than 30
- The United Laboratories and Novo Nordisk Announce Exclusive License Agreement for UBT251, a GLP-1/GIP/Glucagon Triple Receptor Agonist
- Remibrutinib Beneficial for Urticaria After H1-Antihistamine Treatment
- Diet During Pregnancy Might Increase ADHD, Autism Risk
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions